Profile picture

Doctor Felipe Gallego Lima

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)
Membership: FESC Member
Follow
Logo ESC

Contributor content

A randomized, open-label study of the efficacy of trimetazidine in preventing acute myocardial injury in patients hospitalized for moderate to severe acute respiratory syndrome caused by SARS-CoV-2
Presentation
A randomized, open-label study of the efficacy of trimetazidine in preventing acute myocardial injury in patients hospitalized for moderate to severe acute respiratory syndrome caused by SARS-CoV-2

ESC 365 is supported by